Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Combined surgical approach for chronic anal fissure

Official title: Combined Method of Surgical Treatment of Anal Fissure

Run by State Scientific Centre of Coloproctology, Russian Federation · NCT07268261 · Data updated 2026-11-12

This trial tries removing the fissure and giving botulinum toxin A to relax the internal anal sphincter in people with chronic anal fissure to reduce pain, recurrence, and sphincter problems.

More Chronic Anal Fissure trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment122 (estimated)
SponsorState Scientific Centre of Coloproctology, Russian Federation
Government
Locations1 site (Moscow)
StatusRecruiting
StartedSeptember 1, 2023
Main results expectedDecember 1, 2025
Study endsSeptember 1, 2026
Registry record updatedDecember 5, 2025
Trial IDNCT07268261 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with chronic anal fissure lasting more than two months with documented internal sphincter spasm and without exclusion conditions such as inflammatory bowel disease, prior anal canal surgery, significant sphincter insufficiency, pregnancy, or contraindications to botulinum toxin are ideal candidates.

Probably not a fit

Patients with active inflammatory bowel disease, existing anal sphincter insufficiency, prior anal surgeries, pregnancy, lactation, or known hypersensitivity to botulinum toxin are unlikely to be eligible or to receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center interventional program tests a combined surgical approach for chronic anal fissure that pairs fissure excision with postoperative injection of botulinum toxin A to relax the internal anal sphincter. The rationale is that sphincter spasm underlies chronic fissures and that botulinum toxin may reduce postoperative sphincter hypertonia, lowering pain and the risk or duration of sphincter insufficiency. Participants are adults with chronic fissures and internal sphincter spasm who meet exclusion criteria such as inflammatory bowel disease, prior anal surgery, significant sphincter insufficiency, pregnancy, or contraindications to botulinum toxin. The study is conducted at the State Scientific Centre of Coloproctology in Moscow and uses surgical excision followed by botulinum toxin as the interventional protocol; outcomes likely include pain, healing, recurrence, and incontinence though specific endpoints are not listed in the registry entry.

Why it matters

Potential benefit: If successful, this approach could speed healing and reduce postoperative pain, recurrence, and the frequency or duration of sphincter-related incontinence.

How similar studies have gone: Botulinum toxin A has been used with modest success as a non-surgical treatment for chronic anal fissure, but combining fissure excision with immediate botulinum injection is less extensively studied and is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Patients with chronic anal fissure with spasm of anal sphincter

Exclusion Criteria:

* • Inflammatory diseases of the colon

  * Pectenosis
  * Previous surgical interventions on the anal canal
  * IV grade internal and external hemorrhoids
  * Rectal fistula
  * Severe somatic diseases at the decompensation stage
  * Pregnancy and lactation
  * Anal sphincter insufficiency
  * Chronic paraproctitis
  * Individual intolerance and hypersensitivity to botulinum toxin
  * Myasthenia gravis and myasthenic syndromes
  * History of allergic reaction to anticoagulants.
  * Blood diseases (thrombocytopenia, splenomegaly, etc.)

Where it's running

  • SSCCRussia
    Moscow, Russia
    Recruiting

Study contacts

  • Principal investigator: Sergey A. Frolov, Ph.D — State Scientific Centre of Coloproctology, Russian Federation (SSCCRussia)
  • Study coordinator: Evgeny E. Zharkov, MD
  • Email: drzharkov@mail.ru
  • Phone: +79039689739

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.